|
summary: The authors looked at antibodies directed against interferon-beta and found that their presence reduced the levels of markers of its biological efficacy in people with MS on treatment.
authors: Scagnolari C, Duda P, Bagnato F, De Vito G, Alberelli A, Lavolpe V, Girardi E, Durastanti V, Trojano M, Kappos L, Antonelli G.
source: J Neurol. 2007 Apr 10
weblink: click here
category: Immunology
related research news: click here
glossary:
Antibodies
Interferon
Multiple sclerosis
Sclerosis
|
